News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

GlaxoSmithKline (GSK) (JOBS) Sells 4 Drugs to Aspen Pharmacare Ltd. for 170M Pounds (USD $339M)


6/30/2008 8:41:48 AM

LONDON (Reuters) - GlaxoSmithKline Plc (GSK.L: Quote, Profile, Research, Stock Buzz) has sold four of its older drugs to a unit of South Africa's Aspen Pharmacare Holdings (APNJ.J: Quote, Profile, Research, Stock Buzz) for 170 million pounds ($339 million), the world's second biggest drugmaker said on Monday. The medicines involved are Eltroxin, a thyroid hormone for hyperthyroidism; Lanoxin, a cardiac glycoside for heart failure; Imuran, an immunosuppressant; and Zyloric, an enzyme inhibitor for the treatment of gout.

Read at Reuters


comments powered by Disqus
Reuters
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES